Drug Clinical Trials

Caristo has been supporting multiple pharmaceutical and biotech companies’ development efforts by leveraging our capabilities in assessing coronary inflammation, plaque, and radiotranscriptomic profiling.


Caristo can support both pre-clinical and clinical stage drug trials, including:

  • Patient selection  
  • Monitoring treatment efficacy and side effects 
  • Radiotranscriptomic profiling

Collaboration with Agepha Pharma

Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment (LODOCO®-- colchicine, 0.5 mg tablets), announced that they will collaborate with Caristo to improve awareness and clinical education about the central role of inflammation in coronary artery disease.

Read Press Release

Collaboration with Abcentra

Abcentra LLC, a clinical-stage biopharmaceutical company partnered with Caristo Diagnostics to leverage CaRi-Heart AI technology to measure changes in patients’ coronary artery inflammation as a result of therapeutic intervention using Orticumab a monoclonal antibody. CaRi-Heart predicted a 50% reduction in risk of fatal cardiac events...

Read Press Release

Interested in collaborating with us?

Get in touch with the Caristo Team here